These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19837281)

  • 1. The social, political, ethical, and economic aspects of biodefense vaccines.
    Poland GA; Jacobson RM; Tilburt J; Nichol K
    Vaccine; 2009 Nov; 27 Suppl 4(Suppl 4):D23-7. PubMed ID: 19837281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Turning biodefense dollars into products.
    Trull MC; du Laney TV; Dibner MD
    Nat Biotechnol; 2007 Feb; 25(2):179-84. PubMed ID: 17287749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost/success projections for US biodefense countermeasure development.
    Matheny J; Mair M; Smith B
    Nat Biotechnol; 2008 Sep; 26(9):981-3. PubMed ID: 18779804
    [No Abstract]   [Full Text] [Related]  

  • 4. A multidisciplinary approach to an ethic of biodefense and bioterrorism.
    Sutton V
    J Law Med Ethics; 2005; 33(2):310-22. PubMed ID: 16083089
    [No Abstract]   [Full Text] [Related]  

  • 5. E3LSI research: an essential element of biodefense.
    Green SK
    Biosecur Bioterror; 2005; 3(2):128-37. PubMed ID: 16000044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioterrorism: what level is the threat and are vaccines the answer?
    Smith LA
    Expert Rev Vaccines; 2004 Oct; 3(5):493-5. PubMed ID: 15485326
    [No Abstract]   [Full Text] [Related]  

  • 7. Time is running out. Congress' budget inaction considered a threat to bioterrorism preparedness.
    Tieman J
    Mod Healthc; 2002 Oct; 32(43):10. PubMed ID: 12436770
    [No Abstract]   [Full Text] [Related]  

  • 8. Billions for biodefense: federal agency biodefense funding, FY2009-FY2010.
    Franco C
    Biosecur Bioterror; 2009 Sep; 7(3):291-309. PubMed ID: 19772453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conflicts of values and biodefense measures.
    Saha S; Saha P
    IEEE Eng Med Biol Mag; 2004; 23(1):171-4. PubMed ID: 15154274
    [No Abstract]   [Full Text] [Related]  

  • 10. Overview: cause and prevention in biowarfare and bioterrorism.
    Hilleman MR
    Vaccine; 2002 Aug; 20(25-26):3055-67. PubMed ID: 12163257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biodefense research: new tricks to fight old enemies.
    Mariani SM;
    MedGenMed; 2003 May; 5(2):20. PubMed ID: 14603119
    [No Abstract]   [Full Text] [Related]  

  • 12. Federal agency biodefense funding, FY2012-FY2013.
    Franco C; Sell TK
    Biosecur Bioterror; 2012 Jun; 10(2):162-81. PubMed ID: 22691277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological weapons as a strategic threat.
    Bracken P
    Public Health Rep; 2001; 116 Suppl 2(Suppl 2):5-8. PubMed ID: 11880661
    [No Abstract]   [Full Text] [Related]  

  • 14. Preventive vaccines against bioterrorism: evaluation of efficacy and safety.
    Horne AD; Clifford J; Goldenthal KL; Kleppinger C; Lachenbruch PA
    Vaccine; 2004 Nov; 23(1):84-90. PubMed ID: 15519711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Federal funding for health security in FY2015.
    Boddie C; Sell TK; Watson M
    Biosecur Bioterror; 2014; 12(4):163-77. PubMed ID: 24988432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. National leadership in confronting bioterrorism: 2.
    Kennedy EM
    Public Health Rep; 2001; 116 Suppl 2(Suppl 2):116-8. PubMed ID: 11880684
    [No Abstract]   [Full Text] [Related]  

  • 18. Addressing bioterrorism. What ethical issues and questions surround potential responses to bioterrorist attacks?
    Haas JM
    Healthc Exec; 2003; 18(3):76-7. PubMed ID: 12737102
    [No Abstract]   [Full Text] [Related]  

  • 19. Vaccine development for potential bioterrorism agents.
    Titball RW; Williamson ED
    Curr Drug Targets Infect Disord; 2003 Sep; 3(3):255-62. PubMed ID: 14529358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Billions for biodefense: federal agency biodefense budgeting, FY2005-FY2006.
    Schuler A
    Biosecur Bioterror; 2005; 3(2):94-101. PubMed ID: 16000040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.